The level of deubiquitinase USP41 in lung cancer patients was significantly higher than that in normal tissue (Figure 1(a)), and a high expression level of USP41 predicted a poor overall survival rate in lung cancer patients (Figure 1(b)), indicating that USP41 promotes lung cancer progression and may be a prognostic indicator for lung cancer patients. Here, USP41P is linked to lung cancer.